Accelerated Enrollment Solutions (AES), a business of PPD, Inc. has launched a new program to help biopharma companies maintain business continuity during the COVID-19 pandemic by transferring clinical trial patients to AES’ dedicated research sites from other research facilities impacted by the coronavirus crisis.   As academic and hospital-based sites address the front-line care of COVID-19 patients, and as independent sites experience diminished operating capacity related to COVID-19 concer...